Value of Genetic and Genomic Technologies

Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice. Table of Contents Front Matter 1 Introduction 2 Tumor-Based Screening for Lynch Syndrome 3 Pharmacogenomic Testing to Guide Warfarin Dosing 4 Genomic Profiling 5 Closing Remarks References Appendix A: Workshop Agenda Appendix B: Speaker Biographical Sketches Appendix C: Lynch Syndrome Topic Brief Appendix D: Warfarin Topic Brief Appendix E: Genomic Profiling Topic Brief